Mind-NRG Raises $8 Mln
Mind-NRG has closed a Series B financing raising 6 Million EUR (US$8 million). The round was led by LRM, a Belgian based investor specialising in Life Sciences, along with existing investor Index Ventures. Mind-NRG, of Geneva, Switzerland, is developing neuregulins to treat neurodegenerative diseases.
4 September 2013•3 mins read
